InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: None

Friday, 08/09/2019 5:42:05 AM

Friday, August 09, 2019 5:42:05 AM

Post# of 424782

Some analyst comments. Buying Opportunity, Overdone seems to be the theme.


B I O T E C H
@_B_I_O_T_E_C_H_
·
58m
Jefferies $AMRN Adcom Panel Now And Minor Delay ... Likely A Buying Oppt'y
4

B I O T E C H
@_B_I_O_T_E_C_H_
·
59m
Cantor $AMRN No Heartbreak Here, Negative Reaction To AdCom Is Overdone, In Our View
4

B I O T E C H
@_B_I_O_T_E_C_H_
·
1h
STIFL $AMRN FDA Plans To Hold Adcom; We Are Buying The Weakness As Vascepa's sNDA Very Much Approvable, In Our View
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News